| Literature DB >> 27764219 |
Fernando Freitas de Lima1, Sara Emilia Lima Tolouei Menegati2, Giseli Karenina Traesel1, Flávio Henrique Souza de Araújo3, Caroline Honaiser Lescano4, Sara Moraes Peixoto1, Felipe Ariel Mao Silva1, Silvia Cristina Heredia Vieira5, Maria do Carmo Vieira6, Silvia Aparecida Oesterreich1.
Abstract
Attalea phalerata Mart. ex Spreng. (Arecaceae), popularly known as "bacuri", is used in Brazilian folk medicine. ItsEntities:
Mesh:
Substances:
Year: 2016 PMID: 27764219 PMCID: PMC5072689 DOI: 10.1371/journal.pone.0165258
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characterization of the α-carotene and β-carotene values by chromatographic analysis in Attalea phalerata Mart. ex Spreng. oil (APMO).
| Standards | ||
|---|---|---|
| α carotene | β carotene | |
| Retention time (min) | 17.35 | 18.51 |
| Linear Range (μg) | 3–12 | 0.30–2 |
| Intercept(a) | 3995.30 | 4314.30 |
| Slope (b) | 4009.30 | 16411.00 |
| Determination coefficient (R2) | 0.993 | 0.991 |
| Carotenoids concentration (μg/g) | 10.93 | 61.72 |
Linear regression, formula: y = a + bx, where y = ratio of peak areas; x = concentration (μg); a = intercept and b = slope.
Fig 1Effects of the APMO on Artemia salina assay.
Artemia salina nauplii were treated with 10, 50, 100, 250 and 500 μg.mL-1 of oil or vehicle (medium) for 24 h. Results are presented as mean + SEM. n = 4; One-way ANOVA followed by Tukey´s test; *p<0.05 compared to vehicle (medium) and experimental group (10, 50, 100, 250 and 500 μg.mL-1 of oil).
Fig 2Effects of the APMO on cell metabolic activity by MTT assay.
T84 cells were treated with 1, 2.5, 5, 10 and 1 mg.mL-1 of oil or vehicle (medium) for 1h, 24h and 48h. Results are presented as mean + SEM. n = 8; One-way ANOVA followed by Tukey´s test; *p<0.05 compared to vehicle (medium) and experimental group (1, 2.5, 5, 10 and 1 mg.mL-1 of oil).
Effect of the APMO in exposed rats as measured by the comet assay.
The groups were treated with 125, 250, 500 and 1000 mg.kg-1 of the Attalea phalerata Mart. ex Spreng. oil (APMO) daily for 28 consecutive days (four weeks) and the negative control group received the vehicle (saline + Tween 80®). The positive control group received intraperitoneal injection of cyclophosphamide at 20 mg.kg-1.
| Groups | Damage frequency | Classes of damage | Damage index | |||
|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | |||
| Female | ||||||
| Negative Control | 6.20 ± 0.73a | 93.80 ± 0.73 | 6.20 ± 0.73 | 0.00 ± 0.00 | 0.00 ± 0.00 | 6.20 ± 0.73a |
| Cyclophosphamide | 85.40 ± 1.75b | 14.60 ± 1.75 | 41.20 ± 1.07 | 38.80 ± 1.68 | 5.40 ± 1.83 | 135.00 ± 5.07b |
| 125 mg.kg-1 of APMO | 8.40 ± 2.01a | 91.60 ± 2.01 | 8.00 ± 2.07 | 0.40 ± 0.24 | 0.00 ± 0.00 | 8.80 ± 1.98a |
| 250 mg.kg-1 of APMO | 8.60 ± 2.80a | 89.25 ± 2.32 | 10.75 ± 2.32 | 0.00 ± 0.00 | 0.00 ± 0.00 | 8.60 ± 2.80a |
| 500 mg.kg-1 of APMO | 6.20 ± 0.58a | 93.80 ± 0.58 | 5.80 ± 0.66 | 0.40 ± 0.24 | 0.00 ± 0.00 | 6.60 ± 0.60a |
| 1000 mg.kg-1 of APMO | 7.80 ± 2.18a | 90.25 ± 1.25 | 8.75 ± 1.11 | 0.75 ± 0.48 | 0.25 ± 0.25 | 8.80 ± 2.56a |
| Male | ||||||
| Negative Control | 6.60 ± 1.21a | 93.40 ± 1.21 | 6.00 ± 1.38 | 0.60 ± 0.40 | 0.00 ± 0.00 | 7.20 ± 1.16a |
| Cyclophosphamide | 89.60 ± 1.50b | 10.40 ± 1.50 | 41.80 ± 1.69 | 40.60 ± 1.50 | 7.20 ± 1.98 | 144.60 ± 2.87b |
| 125 mg.kg-1 of APMO | 11.80 ± 0.97a | 88.20 ± 0.97 | 9.80 ± 1.16 | 2.00 ± 0.71 | 0.00 ± 0.00 | 13.80 ± 1.24a |
| 250 mg.kg-1 of APMO | 13.20 ± 3.73a | 87.00 ± 3.79 | 12.80 ± 3.83 | 0.40 ± 0.40 | 0.00 ± 0.00 | 13.60 ± 3.67a |
| 500 mg.kg-1 of APMO | 9.00 ± 1.52a | 91.00 ± 1.52 | 8.80 ± 1.50 | 0.20 ± 0.20 | 0.00 ± 0.00 | 9.20 ± 1.56a |
| 1000 mg.kg-1 of APMO | 12.60 ± 2.52a | 87.40 ± 2.52 | 11.40 ± 2.54 | 1.00 ± 0.45 | 0.20 ± 0.20 | 14.00 ± 2.70a |
Negative control—saline solution + Tween 80®; Cyclophosphamide– 20 mg.kg-1ip.; Attalea phalerata Mart. oil at doses of 125, 250, 500 e 1000 mg.kg-1 by gavage. Different letters (a and b) indicate statistically significant differences (p< 0.05) of positive group (cyclophosphamide) between negative control and experimental group (doses 125, 250, 500 e 1000 mg.kg-1); ANOVA/Tukey
Fig 3Effect of the APMO on Micronucleated Polychromatic Erythrocytes (Fig 3A and 3B) and the ratio between Polychromatic Erythrocytes/Normochromatic Erythrocytes—PCE/NCE (Fig 3C and 3D) micronucleus assay.
Groups of female (Fig 3A and 3C) and male (Fig 3B and 3D) rats were treated with 125, 250, 500 and 1000 mg.kg-1 of the APMO daily for 28 consecutive days (four weeks) and the negative control group received the vehicle (saline + Tween 80®). The positive control group received intraperitoneal injection of cyclophosphamide (CPPM) 20mg.kg-1. Results are presented as mean + SEM; One-way ANOVA followed by Tukey´s test; *p<0.05 compared to vehicle (saline) and experimental group (treated with 125, 250, 500 and 1000 mg.kg-1 of the oil).